Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 23, 2024 11:09 ET | Source: Research and Markets

Chemotherapy Treatment Market Research Report 2024-2030: Advancements in Targeted Chemotherapy and Personalized Treatment Plan Developments Driving Growth

Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
December 10, 2024 07:00 ET | Source: FACT.MR

Liver Metastasis Treatment Market to Reach US$ 3.3 Billion, Growing at 6.5% CAGR by 2034 | Fact.MR Report

Rockville, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global liver metastasis treatment market is estimated to reach a...
December 03, 2024 10:04 ET | Source: Research and Markets

Nano Drug Delivery System (NDDS) in Cancer Therapy Global Industry Research Report 2024 - Global Forecast to 2030 with Competitive Profiles of 45+ Key Players

Dublin, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The "NDDS in Cancer Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for NDDS in...
October 14, 2024 10:54 ET | Source: Research and Markets

Chemotherapy Drugs Market Report 2024: Essential Growth Dynamics and Advancements to 2030

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.A...
October 27, 2023 07:31 ET | Source: Persistence Market Research

Oncology Drugs Market Set to Hit $347.3 Billion by 2032 Driven by Rising Cancer Prevalence: Persistence Market Research

New York, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The worldwide oncology drugs market is poised to achieve a market worth of $202.9 billion in 2022, with a projected compound annual growth rate (CAGR) of...
March 30, 2023 16:01 ET | Source: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results

Company focused on the development of Next Generation Chemotherapy drugs in 2023 and out-licensing/business development efforts for non-oncology assets.Dose escalations continue for Next Generation...
March 23, 2023 08:30 ET | Source: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. EST

HANOVER, MD, March 23, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a developer of Next Generation Chemotherapy drugs that provide a better...
March 07, 2023 08:30 ET | Source: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference

HANOVER, MD, March 07, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), the developer of the Next Generation Chemotherapy drugs that will provide...
November 08, 2021 09:10 ET | Source: Research Dive

Global Liver Disease Treatment Market Predicted to Generate a Revenue of $32,028.5 Million at a CAGR of 11.7% during the Forecast Period, 2021-2028 – Exclusive Report [240 Pages] By Research Dive

New York, USA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global liver disease treatment market is predicted to garner $32,028.5 million at a CAGR of...
August 19, 2021 10:25 ET | Source: RAFARMA PHARMACEUTICALS INC

Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs

Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed...

Next Page keyboard_arrow_right